Stocks
APRE Board
$APRE Financing from new and existing healthcare focused investors The proceeds are expected to extend the Company’s cash runway into Q1 2027,

Advertise your business on the APRE board + 18,000 others

Post dates are shown in New York time.

All Stocks

NASDAQ:APRE Aprea Therapeutics Inc Stock Discussion APRE Board

$APRE Financing from new and existing healthcare focused investors The proceeds are expected to extend the Company’s cash runway into Q1 2027,

APRE Board By Allison

December 10, 2025 @ 6:41 am

0 Comments

https://www.globenewswire.com/news-release/2025/12/09/3202351/0/en/Aprea-Therapeutics-Announces-3-1-Million-Private-Placement-Priced-At-The-Market-Under-Nasdaq-Rules.html

Latest from APRE board

Comments 0$APRE Aprea Therapeutics CEO Issues Letter to Shareholders

Comments 0$APRE Aprea Therapeutics (NASDAQ: APRE) “The Street Reports Podcast”

Comments 0$APRE Financing from new and existing healthcare focused investors The proceeds are expected to extend the Company’s cash runway into Q1 2027,

APRE Board

TW ai brings together the latest news headlines, market developments, and social media discussions surrounding Aprea Therapeutics Inc (APRE), providing an AI-generated overview of what's happening and what investors are talking about.

TW ai

Closed After-Hours

Trading Watch Premium members get the latest real-time insights on Aprea Therapeutics Inc (APRE) plus over 18,000 other U.S. stocks.

TW ai has limits - always double check important facts.

Hours Holidays Brokers TW Posts

More from around the web

August 12, 2026 - Aprea Advances APR-1051; Phase 1 Enrollment Accelerates

August 4, 2026 - Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q2 Loss, Tops Revenue Estimates

August 3, 2026 - Lipocine Appoints Michael J. Grissinger to Board of Directors

June 22, 2026 - Next-Generation DNA Repair Therapies Open New Frontiers in Oncology

May 13, 2026 - Earnings Scheduled For May 13, 2026

May 13, 2026 - Aprea Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update

May 7, 2026 - Oracle upgraded, Planet Fitness downgraded: Wall Street's top analyst calls

May 7, 2026 - Here Are Thursday’s Top Wall Street Analyst Research Calls: Alcoa, Chiron Real Estate, Clear Secure, Fortinet, Fresh Pet, Kennametal, Oracle, PayPal, United Therapeutics, and More

April 21, 2026 - Aprea Therapeutics to Provide Clinical Update on ACESOT-1051 Phase 1 Trial Evaluating WEE1 Inhibitor, APR-1051, at ASCO 2026 Annual Meeting

April 2, 2026 - Aprea Therapeutics Closes Oversubscribed $30 Mln Private Placement; Stock Down

March 16, 2026 - Aprea Therapeutics GAAP EPS of -$0.32 beats by $0.07

February 16, 2026 - Most and least shorted healthcare stocks with up to $2B market cap

February 13, 2026 - Aprea Expands Global Patent Protection To Strengthen Its DDR Oncology Pipeline

January 19, 2026 - New Strong Sell Stocks for January 19th

December 18, 2025 - Aprea Therapeutics CEO Issues Letter to Shareholders Highlighting Pipeline Progress in 2025 and Outlook for 2026

November 12, 2025 - Aprea Therapeutics GAAP EPS of -$0.47, revenue of $1.84M

October 24, 2025 - Aprea Therapeutics Provides Clinical Update from ACESOT-1051 Trial Showing Early Signals of Activity for WEE1 Kinase Inhibitor APR-1051

August 28, 2025 - Aprea Therapeutics to Present at H.C. Wainwright Global Investment Conference

August 12, 2025 - Aprea Therapeutics GAAP EPS of -$0.53

June 25, 2025 - Aprea Reports Anti-Proliferative Results and Promising Early-Stage Clinical Data for Next-Generation WEE1 Inhibitor, APR-1051, in HPV+ Head and Neck Squamous Cell Carcinoma (HNSCC) in Collaboration with MD Anderson Cancer Center

May 14, 2025 - Aprea Therapeutics Reports First Quarter 2025 Financial Results and Provides a Clinical Update

March 25, 2025 - Aprea Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update

March 11, 2025 - Aprea Therapeutics Announces Agreement with MD Anderson Cancer Center to Explore APR-1051 as a Potential Treatment for Head and Neck Squamous Cell Carcinoma (HNSCC)

November 9, 2023 - Aprea Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update

October 24, 2023 - Aprea Therapeutics to Host a Key Opinion Leader (KOL) Event on its Synthetic Lethality (SL) and DNA Damage Response (DDR) Pathways

October 16, 2023 - Aprea Unveils Initial Clinical Data on ATRi, ATRN-119, and Pre-Clinical Data on WEE1i, ATRN-1051, at AACR-NCI-EORTC International Conference Supporting Highly Differentiated Synthetic Lethality Portfolio

September 19, 2023 - Aprea Therapeutics Announces Two Posters at the Upcoming 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

September 11, 2023 - Aprea Announces Preclinical Data Supporting Highly Differentiated WEE1 Inhibitor, ATRN-1051, Relative To Other WEE1 Inhibitors

September 6, 2023 - Aprea Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference

August 24, 2023 - Aprea Therapeutics Appoints Dr. Jean-Pierre Bizzari to its Board of Directors and Names Dr. Richard Peters as Chairman

August 10, 2023 - Aprea Therapeutics Reports Second Quarter 2023 Financial Results and Provides Update on Business Operations

July 18, 2023 - Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the Board

June 14, 2023 - Aprea Therapeutics to Present at Maxim Virtual Healthcare Conference

May 30, 2023 - Aprea Therapeutics to Present at BIO International Convention

May 15, 2023 - Aprea Therapeutics Reports First Quarter 2023 Financial Results and Provides Update on Business Operations

May 8, 2023 - Aprea Therapeutics Appoints Gabriela Gruia, M.D. to Board of Directors

March 30, 2023 - Aprea Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Update on Business Operations

March 16, 2023 - Aprea Therapeutics Announces Presentation of Preclinical Data on Pipeline Programs at the AACR 2023 Annual Meeting

March 7, 2023 - Aprea Therapeutics to Present at Oppenheimer’s 33rd Annual Healthcare Conference

March 1, 2023 - Aprea Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

February 27, 2023 - Aprea Therapeutics Announces Closing of $5.5 Million Underwritten Public Offering of Common Stock

February 22, 2023 - Aprea Therapeutics Announces Pricing of $5.5 Million Underwritten Public Offering of Common Stock

February 22, 2023 - Aprea Therapeutics Announces Proposed Public Offering of Common Stock

February 15, 2023 - Aprea Therapeutics Announces Phase II SBIR Award from the National Cancer Institute (NCI)

February 13, 2023 - Aprea Therapeutics Announces One-for-Twenty Reverse Stock Split

January 30, 2023 - Aprea Therapeutics Appoints John Hamill as Chief Financial Officer

January 19, 2023 - Aprea Therapeutics to Participate in 6th Annual DNA Damage and Response (DDR) Inhibitors Summit

January 12, 2023 - Aprea (APRE) Rises on Advancing Lead Drug to Clinical Studies

January 11, 2023 - Aprea Therapeutics Announces Dosing of First Patient in Phase 1/2a Clinical Trial of Oral ATR Inhibitor ATRN-119 for the Treatment of Advanced Solid Tumors

November 9, 2022 - Aprea Therapeutics Reports Third Quarter 2022 Financial Results and Provides Update on Business Operations

Historical Data

Date	Open	High	Low	Close	Volume

Oct 29, 2026	0.54	0.54	0.4856	0.4936	171,488
Oct 28, 2026	0.512	0.54	0.512	0.538	147,500
Oct 27, 2026	0.436	0.536	0.429	0.513	187,900
Oct 26, 2026	0.52	0.52	0.41	0.449	568,600
Oct 23, 2026	0.527	0.546	0.495	0.518	89,200
Oct 21, 2026	0.564	0.6	0.511	0.56	81,600
Oct 20, 2026	0.545	0.567	0.511	0.561	366,900
Oct 19, 2026	0.603	0.605	0.53	0.532	201,100
Oct 16, 2026	0.658	0.658	0.573	0.584	160,100
Oct 15, 2026	0.58	0.626	0.58	0.618	65,400
Oct 14, 2026	0.611	0.611	0.582	0.583	74,300
Oct 13, 2026	0.61	0.648	0.593	0.6	136,900
Oct 12, 2026	0.61	0.615	0.581	0.593	116,500
Oct 9, 2026	0.557	0.607	0.557	0.604	70,400
Oct 8, 2026	0.605	0.61	0.55	0.558	239,400
Oct 7, 2026	0.636	0.638	0.576	0.605	249,900
Oct 6, 2026	0.68	0.68	0.634	0.636	198,900
Oct 5, 2026	0.686	0.695	0.64	0.676	296,500
Oct 2, 2026	0.716	0.736	0.685	0.695	862,200
Oct 1, 2026	0.764	0.782	0.675	0.724	779,600
Sep 30, 2026	0.78	0.82	0.741	0.75	581,700
Sep 29, 2026	0.758	0.82	0.75	0.77	591,600
Sep 28, 2026	0.76	0.771	0.74	0.752	69,800
Sep 25, 2026	0.78	0.78	0.741	0.761	53,300
Sep 24, 2026	0.8	0.8	0.765	0.78	52,000
Sep 23, 2026	0.742	0.81	0.742	0.78	282,000
Sep 22, 2026	0.76	0.76	0.7	0.732	189,600
Sep 21, 2026	0.76	0.76	0.73	0.737	96,700
Sep 18, 2026	0.78	0.78	0.74	0.76	80,000
Sep 17, 2026	0.75	0.772	0.73	0.75	117,200
Sep 16, 2026	0.729	0.757	0.711	0.731	186,000
Sep 15, 2026	0.82	0.82	0.733	0.749	184,200
Sep 14, 2026	0.771	0.843	0.76	0.781	120,300
Sep 11, 2026	0.796	0.82	0.765	0.774	127,300
Sep 10, 2026	0.781	0.81	0.781	0.789	61,300
Sep 9, 2026	0.85	0.871	0.783	0.791	134,700
Sep 8, 2026	0.84	0.88	0.779	0.835	317,800
Sep 4, 2026	0.8	0.809	0.791	0.794	89,400
Sep 3, 2026	0.82	0.82	0.78	0.806	111,700
Sep 2, 2026	0.81	0.854	0.799	0.82	168,800
Sep 1, 2026	0.78	0.9	0.78	0.836	462,400
Aug 31, 2026	0.845	0.852	0.78	0.8	476,000
Aug 28, 2026	0.88	0.91	0.82	0.839	344,000
Aug 27, 2026	0.99	0.99	0.81	0.86	1,182,000
Aug 26, 2026	1.09	1.16	0.923	0.98	2,818,700
Aug 25, 2026	0.815	0.99	0.802	0.95	2,148,900
Aug 24, 2026	0.704	0.85	0.68	0.805	2,803,200
Aug 21, 2026	0.657	0.67	0.623	0.64	14,600
Aug 20, 2026	0.672	0.693	0.633	0.64	38,900
Aug 19, 2026	0.695	0.71	0.668	0.671	52,700
Aug 18, 2026	0.706	0.706	0.672	0.672	10,400
Aug 17, 2026	0.679	0.719	0.67	0.69	49,500
Aug 14, 2026	0.689	0.695	0.657	0.68	15,800
Aug 13, 2026	0.671	0.682	0.656	0.671	21,300
Aug 12, 2026	0.78	0.78	0.656	0.683	28,200
Aug 11, 2026	0.671	0.7	0.655	0.66	24,200
Aug 10, 2026	0.66	0.686	0.639	0.644	30,800
Aug 7, 2026	0.635	0.67	0.601	0.65	38,400
Aug 6, 2026	0.613	0.652	0.613	0.633	22,600
Aug 5, 2026	0.619	0.63	0.6	0.621	67,500
Aug 4, 2026	0.613	0.625	0.599	0.599	67,900
Aug 3, 2026	0.603	0.658	0.59	0.598	152,300
Jul 31, 2026	0.635	0.656	0.607	0.62	50,900
Jul 30, 2026	0.609	0.635	0.609	0.635	18,300
Jul 29, 2026	0.648	0.649	0.6	0.621	138,500
Jul 28, 2026	0.671	0.671	0.6	0.614	85,400
Jul 27, 2026	0.661	0.661	0.617	0.625	19,000
Jul 24, 2026	0.699	0.7	0.613	0.632	18,300
Jul 23, 2026	0.65	0.67	0.612	0.631	30,600
Jul 22, 2026	0.669	0.685	0.65	0.66	24,500
Jul 21, 2026	0.678	0.71	0.65	0.652	43,600
Jul 20, 2026	0.691	0.712	0.662	0.669	22,900
Jul 17, 2026	0.686	0.724	0.65	0.71	74,700
Jul 16, 2026	0.72	0.72	0.661	0.69	47,400
Jul 15, 2026	0.707	0.729	0.69	0.698	35,900
Jul 14, 2026	0.727	0.751	0.601	0.728	145,600
Jul 13, 2026	0.73	0.732	0.688	0.722	45,700
Jul 10, 2026	0.737	0.779	0.73	0.745	15,400
Jul 9, 2026	0.73	0.75	0.727	0.728	43,400
Jul 8, 2026	0.769	0.79	0.74	0.742	35,600
Jul 7, 2026	0.75	0.777	0.732	0.77	71,000
Jul 6, 2026	0.75	0.766	0.71	0.75	72,500
Jul 2, 2026	0.731	0.764	0.73	0.741	131,500
Jul 1, 2026	0.802	0.808	0.71	0.745	166,400
Jun 30, 2026	0.819	0.819	0.751	0.802	107,500
Jun 29, 2026	0.787	0.819	0.734	0.819	61,800
Jun 26, 2026	0.755	0.79	0.722	0.79	40,500
Jun 25, 2026	0.844	0.844	0.78	0.79	23,200
Jun 24, 2026	0.85	0.85	0.794	0.808	46,200
Jun 23, 2026	0.81	0.85	0.794	0.828	124,300
Jun 22, 2026	0.81	0.845	0.72	0.794	373,100
Jun 18, 2026	0.79	0.79	0.71	0.715	76,300
Jun 17, 2026	0.75	0.793	0.71	0.78	61,500
Jun 16, 2026	0.7	0.74	0.694	0.729	98,200
Jun 15, 2026	0.691	0.732	0.691	0.699	52,800
Jun 12, 2026	0.729	0.765	0.65	0.686	383,700
Jun 11, 2026	0.76	0.765	0.693	0.765	89,800
Jun 10, 2026	0.739	0.79	0.739	0.755	78,600
Jun 9, 2026	0.73	0.768	0.698	0.739	91,200
Jun 8, 2026	0.75	0.77	0.73	0.734	56,400
Jun 5, 2026	0.796	0.805	0.73	0.741	109,000
Jun 4, 2026	0.75	0.807	0.75	0.775	51,900
Jun 3, 2026	0.772	0.781	0.71	0.762	124,900
Jun 2, 2026	0.8	0.827	0.76	0.764	127,300
Jun 1, 2026	0.84	0.9	0.802	0.816	230,600
May 29, 2026	0.93	0.95	0.888	0.893	123,800
May 28, 2026	0.915	0.948	0.883	0.931	109,000
May 27, 2026	0.912	0.915	0.89	0.915	91,900
May 26, 2026	0.96	0.97	0.9	0.91	110,500
May 22, 2026	0.9	0.97	0.891	0.95	189,900
May 21, 2026	0.91	0.93	0.826	0.93	194,100
May 20, 2026	0.787	0.9	0.787	0.9	261,500
May 19, 2026	0.871	0.905	0.771	0.8	146,700
May 18, 2026	0.91	0.91	0.829	0.845	160,600
May 15, 2026	0.92	0.989	0.91	0.93	116,200
May 14, 2026	0.9	0.974	0.88	0.941	231,800
May 13, 2026	0.92	0.951	0.86	0.88	241,000
May 12, 2026	0.966	1.002	0.9	0.9	71,800
May 11, 2026	0.99	0.995	0.925	0.93	112,200
May 8, 2026	0.93	1.06	0.903	0.98	974,500
May 7, 2026	0.899	0.948	0.867	0.881	314,400
May 6, 2026	0.83	0.912	0.801	0.834	181,600
May 5, 2026	0.866	0.866	0.816	0.843	190,500
May 4, 2026	0.85	0.861	0.806	0.841	42,100
May 1, 2026	0.79	0.818	0.79	0.818	46,600
Apr 30, 2026	0.81	0.81	0.792	0.8	101,000
Apr 29, 2026	0.83	0.835	0.77	0.819	226,800
Apr 28, 2026	0.85	0.861	0.807	0.837	93,100
Apr 27, 2026	0.952	0.952	0.853	0.861	156,000
Apr 24, 2026	0.89	0.94	0.89	0.93	40,700
Apr 23, 2026	0.95	0.999	0.87	0.884	217,400
Apr 22, 2026	0.93	0.962	0.91	0.95	144,200
Apr 21, 2026	0.991	1.069	0.9	0.907	419,700
Apr 20, 2026	1.02	1.05	0.955	0.981	261,100
Apr 17, 2026	0.908	1.12	0.908	1	1,164,900
Apr 16, 2026	0.934	0.947	0.89	0.908	156,600
Apr 15, 2026	0.93	0.969	0.878	0.943	390,700
Apr 14, 2026	0.821	0.965	0.81	0.941	615,800
Apr 13, 2026	0.86	0.87	0.801	0.847	285,100
Apr 10, 2026	0.761	0.969	0.734	0.917	1,481,800
Apr 9, 2026	0.739	0.739	0.67	0.734	108,200
Apr 8, 2026	0.72	0.739	0.7	0.702	150,200
Apr 7, 2026	0.699	0.711	0.651	0.711	102,100
Apr 6, 2026	0.732	0.741	0.677	0.699	269,700
Apr 2, 2026	0.71	0.73	0.666	0.715	109,400
Apr 1, 2026	0.74	0.744	0.662	0.704	668,800
Mar 31, 2026	0.694	0.8	0.69	0.763	635,800
Mar 30, 2026	0.742	0.806	0.6	0.739	9,790,200
Mar 27, 2026	0.728	0.728	0.683	0.683	77,916
Mar 26, 2026	0.68	0.7099	0.6655	0.7	74,335
Mar 25, 2026	0.665	0.6988	0.665	0.671	14,285
Mar 24, 2026	0.7	0.7096	0.6706	0.6736	54,774
Mar 23, 2026	0.7603	0.762	0.6607	0.6822	76,946
Mar 20, 2026	0.7635	0.79	0.721	0.7622	89,896
Mar 19, 2026	0.7313	0.7801	0.7313	0.7635	41,542
Mar 18, 2026	0.741	0.7599	0.7267	0.7311	33,844
Mar 17, 2026	0.76	0.7907	0.7303	0.7822	73,381
Mar 16, 2026	0.84	0.84	0.7299	0.7561	115,677
Mar 13, 2026	0.7696	0.7698	0.72	0.736	122,726
Mar 12, 2026	0.78	0.8159	0.75	0.765	45,500
Mar 11, 2026	0.828	0.844	0.7801	0.787	111,300
Mar 10, 2026	0.87	0.8709	0.831	0.831	86,396
Mar 9, 2026	0.87	0.8966	0.8403	0.8448	102,667
Mar 6, 2026	0.8932	0.9444	0.8666	0.9002	103,069
Mar 5, 2026	0.8798	0.9499	0.87	0.9217	132,098
Mar 4, 2026	0.832	0.91	0.832	0.91	140,024
Mar 3, 2026	0.8674	0.8748	0.7801	0.849	101,515
Mar 2, 2026	0.9167	0.9167	0.8304	0.8851	121,406
Feb 27, 2026	0.8625	0.9167	0.82	0.9167	110,420
Feb 26, 2026	0.8733	0.8912	0.7812	0.8801	85,308
Feb 25, 2026	0.78	0.88	0.7595	0.875	188,631
Feb 24, 2026	0.8068	0.8149	0.754	0.7999	118,994
Feb 23, 2026	0.771	0.8498	0.75	0.815	165,935
Feb 20, 2026	0.8097	0.84	0.711	0.7578	255,793
Feb 19, 2026	0.7089	0.845	0.7	0.8179	466,172
Feb 18, 2026	0.7055	0.77	0.6447	0.728	4,556,630
Feb 17, 2026	0.6093	0.6102	0.5505	0.6	250,487
Feb 13, 2026	0.5868	0.6439	0.561	0.6094	184,636
Feb 12, 2026	0.642	0.642	0.581	0.5927	178,025
Feb 11, 2026	0.6568	0.658	0.6068	0.6134	81,599
Feb 10, 2026	0.66	0.66	0.6	0.64	135,404
Feb 9, 2026	0.6693	0.68	0.5706	0.66	278,790
Feb 6, 2026	0.6149	0.69	0.5862	0.69	525,672
Feb 5, 2026	0.6512	0.67	0.5996	0.6244	409,151
Feb 4, 2026	0.67	0.7064	0.6384	0.67	436,306
Feb 3, 2026	0.7095	0.7686	0.651	0.6733	1,082,256
Feb 2, 2026	0.745	0.88	0.67	0.7508	2,409,378
Jan 30, 2026	0.615	1.49	0.61	0.796	109,845,000
Jan 29, 2026	0.76	0.76	0.548	0.59	5,565,935
Jan 28, 2026	0.834	0.834	0.73	0.7641	87,430
Jan 27, 2026	0.8	0.8748	0.8	0.829	22,420
Jan 26, 2026	0.843	0.8755	0.811	0.82	59,295
Jan 23, 2026	0.8557	0.8557	0.828	0.83	44,746
Jan 22, 2026	0.8633	0.8789	0.8301	0.8419	98,139
Jan 21, 2026	0.8701	0.914	0.8301	0.832	97,957
Jan 20, 2026	0.89	0.8976	0.871	0.8756	24,726
Jan 16, 2026	0.88	0.946	0.88	0.89	48,353
Jan 15, 2026	0.9	0.9685	0.894	0.894	26,994
Jan 14, 2026	0.92	0.9597	0.89	0.9	95,101
Jan 13, 2026	0.9201	0.99	0.9025	0.9025	98,475
Jan 12, 2026	0.93	0.9693	0.92	0.92	25,637
Jan 9, 2026	0.98	1	0.903	0.9452	87,452
Jan 8, 2026	0.9485	0.9501	0.8737	0.9401	129,976
Jan 7, 2026	0.912	0.9656	0.882	0.9	55,758
Jan 6, 2026	0.8925	1	0.8925	0.912	131,474
Jan 5, 2026	0.84	0.888	0.84	0.8783	163,294
Jan 2, 2026	0.871	0.88	0.84	0.853	55,362
Dec 31, 2025	0.86	0.914	0.84	0.853	153,516
Dec 30, 2025	0.92	0.944	0.88	0.89	100,068
Dec 29, 2025	1.01	1.01	0.8985	0.9204	62,289
Dec 26, 2025	0.955	1.02	0.955	0.9802	22,781
Dec 24, 2025	0.97	0.97	0.95	0.9512	24,117
Dec 23, 2025	0.94	0.98	0.932	0.9517	16,151
Dec 22, 2025	0.9408	0.98	0.9301	0.9313	51,480
Dec 19, 2025	0.93	0.94	0.9055	0.93	54,723
Dec 18, 2025	0.91	0.9398	0.91	0.9101	59,590
Dec 17, 2025	0.9063	0.93	0.9063	0.9102	26,795
Dec 16, 2025	0.9301	0.9301	0.9101	0.911	21,337
Dec 15, 2025	0.94	0.9676	0.9203	0.9251	34,152
Dec 12, 2025	0.95	0.978	0.9349	0.9349	84,163
Dec 11, 2025	0.95	0.9894	0.94	0.945	123,386
Dec 10, 2025	1	1	0.901	0.9122	108,838
Dec 9, 2025	1.04	1.04	0.9	0.9277	230,159
Dec 8, 2025	1.06	1.1399	1.02	1.04	129,085
Dec 5, 2025	1.08	1.09	1.04	1.06	26,573
Dec 4, 2025	0.999	1.14	0.99	1.06	88,338
Dec 3, 2025	1	1.08	0.9602	1.03	99,068
Dec 2, 2025	1.1301	1.1307	1.005	1.02	109,720
Dec 1, 2025	1.25	1.2601	1.11	1.11	85,591
Nov 28, 2025	1.25	1.28	1.25	1.26	18,438
Nov 26, 2025	1.23	1.2885	1.23	1.25	18,042
Nov 25, 2025	1.16	1.215	1.14	1.21	12,286
Nov 24, 2025	1.24	1.2499	1.1386	1.17	22,338
Nov 21, 2025	1.11	1.17	1.0777	1.17	30,699
Nov 20, 2025	1.18	1.2299	1.1	1.11	85,875
Nov 19, 2025	1.21	1.2771	1.17	1.2	44,218
Nov 18, 2025	1.18	1.2199	1.15	1.19	61,609
Nov 17, 2025	1.2	1.25	1.15	1.19	22,134
Nov 14, 2025	1.18	1.24	1.1528	1.21	41,751
Nov 13, 2025	1.23	1.245	1.17	1.19	607,912
Nov 12, 2025	1.28	1.29	1.2302	1.26	29,574
Nov 11, 2025	1.27	1.32	1.27	1.32	18,838
Nov 10, 2025	1.24	1.27	1.21	1.27	29,125
Nov 7, 2025	1.23	1.29	1.2201	1.23	36,246
Nov 6, 2025	1.31	1.33	1.19	1.2	44,406
Nov 5, 2025	1.36	1.38	1.31	1.312	73,911
Nov 4, 2025	1.36	1.4	1.36	1.37	39,876
Nov 3, 2025	1.4	1.45	1.39	1.4	51,457
Oct 31, 2025	1.45	1.46	1.39	1.4	47,163
Oct 30, 2025	1.44	1.47	1.4	1.45	40,998
Oct 29, 2025	1.45	1.49	1.41	1.45	92,606

Explore Stocks

Search Posts All Stocks Featured Stocks 52-Week Lows AI Stocks Semiconductor Stocks Energy Stocks Finance Stocks Healthcare Stocks Software Stocks Crypto Stocks Oil Stocks Mining Stocks Biotech Stocks Pharmaceutical Stocks Fintech Stocks Retail Stocks Food Stocks Car Stocks Telecommunications Stocks Aerospace & Defense Stocks Entertainment Stocks Travel Stocks Logistics Stocks Search Engine Stocks Social Media Stocks Cannabis Stocks Marijuana Stocks CBD Stocks

Important Disclaimer: We cannot guarantee the accuracy of any information found here and recommend that you do your due diligence before making any investment.

Advanced Search